ArticleCancers2023

Potential Biomarkers Associated with Prognosis and Trastuzumab Response in HER2+ Breast Cancer.

Ana Carla Castro-Guijarro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.